Molecular targets of dietary agents for prevention and therapy of cancer

Bharat B Aggarwal1, Shishir Shishodia

  • 1Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Box 143, 1515 Holcombe Boulevard, Houston, TX 77030, USA. aggarwal@mdanderson.org

Insights

Fruits and vegetables contain active compounds that can target multiple cell-signaling pathways, offering potential for cancer prevention and treatment. This review highlights dietary agents and their molecular mechanisms in combating diseases.

Area of Science:

  • * Nutritional Biochemistry
  • * Molecular Oncology
  • * Phytochemistry

Background:

  • * Fruits and vegetables are linked to disease prevention, but their molecular mechanisms are not fully understood.
  • * Targeted cancer monotherapy has limitations due to bypass mechanisms, necessitating combination therapies or multi-pathway agents.
  • * Identifying active compounds in foods and their molecular targets is crucial for understanding their therapeutic potential.

Purpose of the Study:

  • * To review evidence on how agents from fruits and vegetables interfere with multiple cell-signaling pathways.
  • * To highlight specific dietary compounds and their molecular targets relevant to cancer prevention and treatment.
  • * To underscore the potential of dietary agents as therapeutic interventions.

Main Methods:

  • * Comprehensive literature review of research on phytochemicals and their effects on cell signaling.
  • * Identification of key active compounds from fruits and vegetables and their associated molecular targets.
  • * Analysis of studies demonstrating the multi-pathway inhibitory effects of these compounds.

Main Results:

  • * Numerous agents from fruits and vegetables, including curcumin, resveratrol, and genistein, modulate critical cell-signaling pathways.
  • * Specific examples, like curcumin, inhibit pathways such as NF-kappaB, STAT3, Akt, and MAPK.
  • * Identified active principles and modulated molecular targets provide a basis for the preventive and therapeutic roles of these dietary agents.

Conclusions:

  • * Dietary agents from fruits and vegetables possess the ability to interfere with multiple cell-signaling pathways.
  • * These compounds show promise for both preventing and treating cancer and other diseases.
  • * The findings support the concept of 'food as medicine' for health and disease management.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...